Wilson Troy Edward
CIK 0001589597
President and CEODirector
Filings
29
Latest Mar 25, 2026
Issuers covered
4
Showing
29 of 29
Page 1
Track record
10 of 18 open-market trades scored (56% price coverage) - 8 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 10 | 40% | +3.9% | -3.1% | +42.3% | -20.5% |
| 90 days | 10 | 80% | +16.3% | +4.5% | +66.5% | -34.3% |
| 180 days | 10 | 50% | -8.7% | +1.6% | +25.3% | -83.3% |
| 365 days | 5 | 40% | +15.9% | -0.9% | +58.1% | -33.3% |
Issuers
Companies where Wilson Troy Edward has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| KURA | Kura Oncology, Inc. | 13 | Mar 25, 2026 |
| RNA | Avidity Biosciences, Inc. | 8 | Feb 27, 2026 |
| PBYI | Puma Biotechnology, Inc. | 7 | Jun 17, 2025 |
| RNA | Atrium Therapeutics, Inc. | 1 | Mar 2, 2026 |
All filings
29 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|